Big Pharma’s business-as-usual playbook relies on egregious pricing practices and rhetoric designed to set and keep drug prices high.

Drug prices in the United States are out of control as a direct result of the egregious pricing and anti-competitive practices of brand name pharmaceutical companies. Rising prescription drug prices threaten the affordability of our health care system, the long-term health of our nation and the vitality of our entire economy. Public opinion research finds as many as one-in-three Americans experience financial difficulty, either as a patient themselves or through a family member, affording prescription drugs. CSRxP has developed market-based solutions to restore a functioning market and lower prices for patients by increasing list price transparency, promoting competition and actual innovation and focusing on better value for patients, not better value for pharmaceutical companies.

Jul 23, 2024

BIG PHARMA EARNINGS: JOHNSON & JOHNSON AND NOVARTIS

Big Pharma Giants Top Wall Street Expectations After Hiking Prices on Prescription Drugs

Jul 15, 2024

CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES

Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate of

Jul 15, 2024

ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. SENATE PASSAGE OF PATENT THICKET CRACKDOWN

Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma Accountable

Jul 11, 2024

CSRXP APPLAUDS U.S. SENATE PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS

Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics That Extends

Jul 23, 2024

BIG PHARMA EARNINGS: JOHNSON & JOHNSON AND NOVARTIS

Big Pharma Giants Top Wall Street Expectations After Hiking Prices on Prescription Drugs

Jul 15, 2024

CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES

Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate of

Jul 15, 2024

ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. SENATE PASSAGE OF PATENT THICKET CRACKDOWN

Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma Accountable

Jul 11, 2024

CSRXP APPLAUDS U.S. SENATE PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS

Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics That Extends

Videos

Watch and learn about Big Pharma’s price-gouging techniques that are the cause of out-of-control drug prices.

Fact Sheets

Get the facts on Big Pharma’s anti-competitive tactics, like price-gouging and patent abuse that keeps drug prices high.

Infographics

Learn about how Big Pharma is driving the Rx drug pricing crisis with our infographics.

Polling

See recent surveys on American voters’ opinions on Big Pharma’s blame game and out-of-control drug pricing.

Join us in telling lawmakers: It’s time to hold Big Pharma accountable and lower Rx drug prices.

By signing your name, you are opting-in to receive calls and SMS/MMS messages, including autodialed and automated calls and texts, to that number from CSRxP. Msg & data rates may apply.
This field is for validation purposes and should be left unchanged.